Plus Therapeutics (PSTV) Investor Presentation- Slideshow

The ReSPECT-GBM Phase 1/2a Trial of Rhenium-186 NanoLiposome ( 186RNL) in Recurrent Glioma via Convection-Enhanced Delivery (CED) Abstract 277O Andrew J. Brenner1, Ande Bao1, William Phillips1, Joel E. Michalek1, Marc H Hedrick2, Norman LaFrance2, Toral R. Patel3, Jeffrey S. Weinberg4, John Floyd1 1Mays Cancer Center at UT Health San Antonio, Texas, USA 9 September 2022; 2Plus Therapeutics, Austin, TX USA; 3UT Southwestern, Dallas Texas, USA; 4MD Anderson Cancer Center, Houston, TX, USA | --- | --- | --- | ...